Holen Sie sich die Stockscreener-App
2.84
2.07%
-0.06
Anixa Biosciences Inc Aktie (ANIX) Neueste Nachrichten
Anixa Biosciences highlights progress in breast cancer vaccine on Bloomberg TV this Saturday. - Pluang
A breast cancer survivor will discuss Anixa's vaccine on TV - Stock Titan
Anixa Biosciences Inc expected to post a loss of 9 cents a shareEarnings Preview - TradingView
Anixa Biosciences to Present at the Nasdaq & LD Micro Inaugural SF Summit on September 9, 2026 - PR Newswire
Anixa Biosciences (ANIX) Projected to Post Earnings on Wednesday - MarketBeat
Anixa Biosciences Inc. (ANIX) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Anixa Biosciences Inc. (ANIX) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Anixa Biosciences Inc (NASDAQ:ANIX) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Anixa Biosciences to Present at the 2026 Cantor Fitzgerald Global Healthcare Conference Highlighting its Breast Cancer Vaccine and Ovarian Cancer CAR-T Therapy - AOL.ca
Breast cancer vaccine meets Phase 1 goals; ovar... - Pluang
Anixa Biosciences (NASDAQ:ANIX) Stock Rating Lowered by Zacks Research - MarketBeat
Spotlighting Anixa Biosciences And 2 Other Noteworthy Penny Stocks - Sahm
Anixa (ANIX) Range: Slides 2.70% to $3.61 in the Latest Reading; Level Watch - vinanet.vn
Anixa (ANIX) Latest Results Brief: EPS Prints Above Forecast at the Close; Post-Earnings Trading: Shares Finish 3.30% Lower in the Latest ReadingEBITDA Analysis - vinanet.vn
Anixa Biosciences to Present at the H.C. Wainwright 28th Annual Global Investment Conference - PR Newswire
Anixa Biosciences to present at H.C. Wainwright Global Investment Conference - Bitget
Anixa Biosciences (ANIX) Surges 7.7% as Biotech Momentum BuildsCorrective Wave - vinanet.vn
Anixa Biosciences (ANIX) Slips 0.63% to $3.18 as Shares Consolidate Between Key Support and ResistancePre-Earnings Momentum - vinanet.vn
ANIX Q2 2026 Earnings: Narrower Loss of $0.07 per Share Beats Estimates Amid Steady Pipeline Execution - vinanet.vn
Anixa Biosciences (ANIX) Holds Near $3.42 as Traders Eye Key Support and Resistance LevelsVolatility Term Structure - vinanet.vn
Anixa Biosciences (NASDAQ:ANIX) CEO Amit Kumar Buys 5,000 Shares - MarketBeat
Anixa Biosciences (ANIX) CEO Amit Kumar Buys 5,000 Shares, Insider Ownership Climbs to 657,000 Shares - GuruFocus
Anixa Biosciences CEO Amit Kumar buys $17,350 in company stock By Investing.com - Investing.com Nigeria
Form 4 Anixa Biosciences Inc For: 3 August By Investing.com - Investing.com Nigeria
Anixa Biosciences (ANIX) CEO purchases 5,000 company shares - Stock Titan
Anixa Biosciences Inc (NASDAQ:ANIX) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Form 4 Anixa Biosciences Inc For: 29 July By Investing.com - Investing.com Nigeria
Anixa Biosciences (NASDAQ:ANIX) CEO Acquires $17,200.00 in Stock - MarketBeat
Anixa Biosciences (NASDAQ:ANIX) CEO Acquires 3,000 Shares - MarketBeat
Anixa Biosciences (NASDAQ: ANIX) CEO buys 5,000 shares, now holds 652,000 - Stock Titan
Anixa Biosciences Inc (ANIX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Form 4 Anixa Biosciences Inc For: 27 July By Investing.com - Investing.com Nigeria
Anixa Biosciences (ANIX) CEO purchases 3,188 shares at $3.37 each - Stock Titan
Anixa Biosciences CEO Amit Kumar buys $11,190 in company stock - Investing.com
Anixa Biosciences CEO Amit Kumar buys $11,190 in company stock By Investing.com - Investing.com Canada
Anixa Biosciences Inc (ANIX) CEO purchases 3,000 shares at $3.73 - Stock Titan
Anixa Biosciences Inc (ANIX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Anixa Biosciences Inc (ANIX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Anixa Biosciences, Inc. Revenue Breakdown – NASDAQ:ANIX - TradingView
Anixa Biosciences Inc (ANIX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
ANIX|Anixa Biosciences Inc|Price:3.700|Chg%:-0.050 - TradingKey
TradingKey - TradingKey
Anixa Biosciences Inc (ANIX) Valuation: PE, PB & Fair Value Analysis - TradingKey
ANIX|Anixa Biosciences Inc|Price:3.725|Chg%:+0.025 - TradingKey
ANIX|Anixa Biosciences Inc|Price:3.680|Chg%:-0.020 - TradingKey
Anixa Biosciences Inc (ANIX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Anixa Biosciences (NASDAQ:ANIX) Rating Increased to Strong-Buy at Zacks Research - MarketBeat
Anixa Biosciences (ANIX) Upgraded to Strong Buy: Here's What You Should Know - Yahoo Finance UK
New Strong Buy Stocks for July 22nd - The Globe and Mail
Are Medical Stocks Lagging Allarity Therapeutics, Inc. (ALLR) This Year? - finance.yahoo.com
CEO Amit Kumar Increases Stake in Anixa Biosciences Inc - GuruFocus
3 Penny Stocks With Market Caps Over $100M To Consider - Sahm
Anixa Biosciences (ANIX) CEO buys 5,000 common shares - Stock Titan
Anixa Biosciences Inc. (ANIX) Q2 2026 Earnings: Narrower-Than-Expected Loss as Clinical Pipeline Advances - dars.gov.et
Insider Buying: Titterton Lewis H Jr Acquires Additional Shares of Anixa Biosciences Inc (ANIX) - GuruFocus
Anixa Biosciences (ANIX) director purchases 12,000 shares of common stock - Stock Titan
0.29%
4.16%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):